Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL26645121

C#Cc1ccc(-c2nn3c(c2-c2ccncc2)CNCC3)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.36
MAPK14 Q16539 4/20 0.34
CSNK1D P48730 5/20 0.34
CSNK1E P49674 4/20 0.34
CSNK1A1 P48729 1/20 0.33
BRAF P15056 2/20 0.33
KDR P35968 2/20 0.33
TLR9 Q9NR96 2/20 0.32
TLR8 Q9NR97 2/20 0.32
TLR7 Q9NYK1 2/20 0.32
HTR3A P46098 1/20 0.32
DPP4 P27487 1/20 0.31
DPP7 Q9UHL4 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
RAD52 P43351 1/20 0.30
UBE2N P61088 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
KCNH2 Q12809 1/20 0.30
MAPK11 Q15759 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL26645592 0.88 MAPK14 (0.45) MAPK14CSNK1DCSNK1EBRAFKDR
SCHEMBL26645659 0.80 BRAF (0.46) MAPK14CSNK1DCSNK1ECSNK1A1BRAF
Hydrochloric Acid SCHEMBL26645698 0.79 BRAF (0.46) MAPK14CSNK1DCSNK1ECSNK1A1BRAF
Hydrochloric Acid SCHEMBL26645132 0.79 MAPK14 (0.45) MAPK14BRAFKDRMAPK11SRC
Hydrochloric Acid SCHEMBL26645137 0.79 MAPK14 (0.45) MAPK14BRAFKDRHTR3AMAPK11
SCHEMBL24554415 0.78 MAPK14 (0.53) MAPK14CSNK1DCSNK1ECSNK1A1BRAF
Hydrochloric Acid SCHEMBL26645368 0.77 MAPK14 (0.52) MAPK14CSNK1DCSNK1ECSNK1A1BRAF
Hydrochloric Acid SCHEMBL26645048 0.77 MAPK14 (0.43) MAPK14CSNK1DCSNK1EBRAFKDR
Hydrochloric Acid SCHEMBL26645169 0.76 PTGS2 (0.39) MAPK14BRAFKDRHTR3ASRC
SCHEMBL26645228 0.76 SRC (0.43) MAPK14BRAFKDRMAPK11SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 WO disclosed